mouse primary lung epithelial cell line mle12 (ATCC)
Structured Review

Mouse Primary Lung Epithelial Cell Line Mle12, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1005 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+lung+epithelial+cell+line+mle12/bio_rxiv__64898__2026__05__19__726266-38-7-17?v=ATCC
Average 97 stars, based on 1005 article reviews
Images
1) Product Images from "Cryptochrome Loss Drives COPD-like Lung Pathology through Disrupted Alveolar Epithelial Proliferation and Immune Homeostasis"
Article Title: Cryptochrome Loss Drives COPD-like Lung Pathology through Disrupted Alveolar Epithelial Proliferation and Immune Homeostasis
Journal: bioRxiv
doi: 10.64898/2026.05.19.726266
Figure Legend Snippet: MLE12 cells were transfected with 50 pmole/ml control, Cry1 , or Cry2 siRNA on day 0 and day 1. A. Western blot showed CRY1/CRY2 protein levels on day 2. B. The transcript levels of cytokines, including C-C motif chemokine ligand 2 ( Ccl2 ), C-X-C motif chemokine ligand 1 ( Cxcl1 ), Interleukin-6 ( Il6 ), Il8/Cxcl5 , matrix metalloproteinase 1 and 7 ( Mmp1 and Mmp7 ), and Tnfa were determined with RT-qPCR. C. Cell numbers were measured with the WST1 assay 1-, 2-, or 3-days post siRNA transfection. n=6. D-E. Primary alveolar ECs were isolated from WT or Cry1/2 dKO mice for RNA sequencing analysis. D. Heatmap image of up (501) and down (369) regulated genes in Cry1/2 dKO mice alveolar ECs compared to WT alveolar ECs. Each gene is represented as a horizontal line. E. GO Biological Process (BP) analysis of DEGs that were in Cry1/2 dKO lung ECs. F. GO Molecular Function (MF) analysis of DEGs. G. GO Cellular Component (CC) analysis of DEGs. The top 5 terms were shown for both up and down-regulated genes. H. Enriched pathways (Metascape) of overlapping genes from human COPD patient ECs DEGs with DEGs from (D). I. GO BP, J. MF and K . CC analysis of common genes between human COPD patient lungs with DEGs in Cry1/2 dKO ECs. Data are presented as mean ± SEM. ** p<0.1, *** p<0.001, and **** p<0.0001 Cry1/2 si vs si_con (Two-way ANOVA followed by Bonferroni adjusted multiple comparisons). For C , only the asterisks for si- Cry1/2 are shown.
Techniques Used: Transfection, Control, Western Blot, Quantitative RT-PCR, Isolation, RNA Sequencing
Figure Legend Snippet: A. Experimental schematic: Cry1/2 dKO mice were fed with regular (RD) or 1% NOB-containing diets starting at 1 month old and analyzed at 4 months. B. Representative images of H&E-stained lung sections collected from mice fed with a RD or NOB diet. C. MLI quantification of H&E-stained lung sections from male or female Cry1/2 dKO fed with RD or NOB diets. D. RNA-seq was performed using primary lung ECs isolated from the WT mice, or Cry1/2 dKO mice fed with RD or NOB diet. Heatmap of RNA-seq data of lung ECs from different treatment groups. E. GO BP analysis of DEGs that were rescued by NOB treatment in Cry1/2 dKO lung ECs. F. GO MF analysis of rescued DEGs. G. GO CC analysis of rescued DEGs. H. RT qPCR confirmed the upregulation and rescue of genes involved in cilium movement. I. The transcript expression changes of important differentially expressed chemokines, cytokines, Mmps , and surfactant proteins from RNA-seq data. Data were presented as fold changes to WT. J. MlE12 cells were transfected with control siRNA or siRNA targeting Cry1 and Cry2 . 36 h after transfection, cells were treated with 5 ng/ml TNF-α for 15 min. Phosphorylated P-65 and P65 levels were determined with Western blots. K. MLE12 cells were treated with 20 µM NOB for 24 h, followed by 5 ng/ml TNF-α for 0, 15, or 30 mins. Phosphorylated P-65 and P65 levels were determined with Western blots. L. MLE12 cells were transfected with control siRNA, or siRNA targeting Cry1 and Cry2 , and treated with 20 µM NOB for 24 h before TNF-α stimulation (15 mins). Representative confocal images of p65 (green) are shown (×400 magnification; scale bar = 10 µm). M. The percentage of cells with p65 localized in the cytoplasm (C), both cytoplasm and nucleus (C+N), or nucleus (N) was quantified for each treatment condition. N. Western blot of CRY1/2 and COPD-associated proteins in primary lung ECs from different treatment groups. Data are presented as mean ± SEM. P-value was calculated from a two-tailed t-test for H and I, * p<0.05, ** p<0.01, *** p<0.001, and **** p<0.0001 in RD vs in Cry1/2 dKO samples.
Techniques Used: Staining, RNA Sequencing, Isolation, Quantitative RT-PCR, Expressing, Transfection, Control, Western Blot, Two Tailed Test



